Join today and be a part of the fastest growing B2B Network Join Now

IMB RUVICA (ibru tinib)

  • Origin: Poland
  • Supply Type: oem service
  • Processing Time: 3 Days

Supplier Info.

  • Employees Total 11-50
  • Annual Revenue US$2.5 Million - US$5 Million

IMBRU VICA® (ibru tinib) is a cancer medicine that interferes with the growth and spread of cancer in the body.

Imbru vica is used to treat mantle lymma, marginal zone lymma, Waldenstrom's macroglobuchronic lymcytic leukemia, and small lymcytic lymma.

us for further details:

Premium Services
Tell us what you need
Girl Right
Cross Popup
Arrow 2

I Am :

Signup today to claim your Discount. Get Started before it's too late!

Arrow 1
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok